Literature DB >> 31620222

Aminoquinoline-Rhodium(II) Conjugates as Src-Family SH3 Ligands.

Samuel C Martin1, Zachary T Ball1.   

Abstract

High-affinity, selective ligands are sought for a variety of biomolecules but are particularly difficult to generate in the protein-protein interaction space. Rhodium(II) conjugates provide a structure-based approach to improved affinity and specificity for targeting protein-protein interactions such as SH3 domains. In this study of small-molecule-rhodium conjugates, we report a potent ligand 4b (K d of 27 nM) for the Lyn SH3 domain, based on an aminoquinoline fragment. The results demonstrate robust affinity gains possible from even modest small-molecule leads through cooperative inorganic-organic binding, based on specific histidine interactions. A docking study sheds light on the structural basis of binding and supports a previously proposed binding model.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31620222      PMCID: PMC6792148          DOI: 10.1021/acsmedchemlett.9b00309

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  37 in total

1.  UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.

Authors:  Chitose Oneyama; Hirofumi Nakano; Sreenath V Sharma
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

Review 2.  Structure and regulation of Src family kinases.

Authors:  Titus J Boggon; Michael J Eck
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

Review 3.  Reaching for high-hanging fruit in drug discovery at protein-protein interfaces.

Authors:  James A Wells; Christopher L McClendon
Journal:  Nature       Date:  2007-12-13       Impact factor: 49.962

Review 4.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

5.  Designing Selectivity in Dirhodium Metallopeptide Catalysts for Protein Modification.

Authors:  Samuel C Martin; Farrukh Vohidov; Haopei Wang; Sarah E Knudsen; Alex A Marzec; Zachary T Ball
Journal:  Bioconjug Chem       Date:  2017-01-17       Impact factor: 4.774

Review 6.  Ferrocifen type anti cancer drugs.

Authors:  Gérard Jaouen; Anne Vessières; Siden Top
Journal:  Chem Soc Rev       Date:  2015-10-21       Impact factor: 54.564

7.  Synthesis of 5-, 6- and 7-substituted-2-aminoquinolines as SH3 domain ligands.

Authors:  Steven Inglis; Rhiannon Jones; Daniel Fritz; Cvetan Stojkoski; Grant Booker; Simon Pyke
Journal:  Org Biomol Chem       Date:  2005-06-13       Impact factor: 3.876

8.  6-Substituted 1H-quinolin-2-ones and 2-methoxy-quinolines: synthesis and evaluation as inhibitors of steroid 5alpha reductases types 1 and 2.

Authors:  E Baston; A Palusczak; R W Hartmann
Journal:  Eur J Med Chem       Date:  2000-10       Impact factor: 6.514

9.  A dual-functional molecular strategy for in situ suppressing and visualizing of neuraminidase in aqueous solution using iridium(iii) complexes.

Authors:  Chun Wu; Ke-Jia Wu; Jin-Biao Liu; Xiao-Ming Zhou; Chung-Hang Leung; Dik-Lung Ma
Journal:  Chem Commun (Camb)       Date:  2019-05-30       Impact factor: 6.222

Review 10.  Src family kinases: regulation of their activities, levels and identification of new pathways.

Authors:  Evan Ingley
Journal:  Biochim Biophys Acta       Date:  2007-08-22
View more
  2 in total

Review 1.  Fragment-to-Lead Medicinal Chemistry Publications in 2020.

Authors:  Iwan J P de Esch; Daniel A Erlanson; Wolfgang Jahnke; Christopher N Johnson; Louise Walsh
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

2.  ADAM8 signaling drives neutrophil migration and ARDS severity.

Authors:  Catharina Conrad; Daniela Yildiz; Simon J Cleary; Andreas Margraf; Lena Cook; Uwe Schlomann; Barry Panaretou; Jessica L Bowser; Harry Karmouty-Quintana; Jiwen Li; Nathaniel K Berg; Samuel C Martin; Ahmad Aljohmani; S Farshid Moussavi-Harami; Kristin M Wang; Jennifer J Tian; Mélia Magnen; Colin Valet; Longhui Qiu; Jonathan P Singer; Holger K Eltzschig; Wilhelm Bertrams; Susanne Herold; Norbert Suttorp; Bernd Schmeck; Zachary T Ball; Alexander Zarbock; Mark R Looney; Jörg W Bartsch
Journal:  JCI Insight       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.